Headline,Date,Label
Bard Financial Services Inc. Raises Stake in Roche Holding AG (OTCMKTS:RHHBY),2023-12-24,positive
Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform,2023-12-29,positive
Roche Holding AG (OTCMKTS:RHHBY) Sees Significant Decline in Short Interest,2024-01-01,negative
Roche Holding AG (OTCMKTS:RHHBY) Shares Purchased by Beach Investment Counsel Inc. PA,2024-01-02,positive
Remix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modulating RNA Processing,2024-01-03,positive
"Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024",2024-01-07,positive
Stock Down 13% Today?,2024-01-08,negative
Roche Holding AG (OTCMKTS:RHHBY) Stake Lessened by Dividend Assets Capital LLC,2024-01-08,positive
Roche Holding AG (OTCMKTS:RHHBY) Shares Sold by Meritage Portfolio Management,2024-01-13,positive
First Horizon Advisors Inc. Buys 487 Shares of Roche Holding AG (OTCMKTS:RHHBY),2024-01-16,positive
Morgan Stanley Downgrades Roche (OTCMKTS:RHHBY) to Underweight,2024-01-16,negative
Roche Holding AG (OTCMKTS:RHHBY) Given Average Rating of “Hold” by Brokerages,2024-01-16,positive
"European Commission approves Roche's Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types",2024-01-16,positive
